Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

May 03, 2015 11:32 AM ET


Company Overview of OPX Biotechnologies, Inc.

Company Overview

OPX Biotechnologies, Inc. develops and produces bio-based chemicals and fuels. It offers bioacrylic, a sustainable and affordable direct replacement for petro-acrylic; and fatty acids and derivatives. The company has strategic partnerships with The Dow Chemical Company, Evonik, and Johnson Matthey. OPX Biotechnologies, Inc. was founded in 2007 and is based in Boulder, Colorado. As of April 28, 2015, OPX Biotechnologies, Inc. operates as a subsidiary of Cargill, Incorporated.

2425 55th Street

Suite 100

Boulder, CO 80301

United States

Founded in 2007





Key Executives for OPX Biotechnologies, Inc.

Chief Executive Officer, President and Director
Co-Founder and Chief Scientific Officer
Chief Financial Officer
Age: 50
Vice President of Engineering and Operations
Chief Technology Officer and Vice President of Research & Development
Compensation as of Fiscal Year 2014.

OPX Biotechnologies, Inc. Key Developments

OPX Biotechnologies, Inc. Presents at World Congress on Industrial Biotechnology, May-12-2014

OPX Biotechnologies, Inc. Presents at World Congress on Industrial Biotechnology, May-12-2014 . Venue: Philadelphia, Pennsylvania, United States.

OPX Biotechnology Presents at Advanced Biofuels Leadership Conference, Oct-09-2013 02:00 PM

OPX Biotechnology Presents at Advanced Biofuels Leadership Conference, Oct-09-2013 02:00 PM. Venue: Intercontinental San Francisco Hotel, San Francisco, California, United States. Speakers: Chas Eggert, CEO.

Evonik Industries AG Selects OPX Biotechnologies, Inc. for Joint Development of Bio-Based Chemicals

OPX Biotechnologies, Inc. and Evonik Industries AG announced the two companies have entered into an agreement to jointly develop certain bio-based specialty chemicals. The joint-development agreement signed May 3, 2013 calls for OPXBIO to use its proprietary EDGE(TM) (Efficiency Directed Genome Engineering) technology to develop the bio-processes. According to the agreement, OPXBIO will also be able to market bio-based products resulting from the Evonik collaboration.

Similar Private Companies By Industry

Company Name Region
Special Materials Company United States
Village Plastics, Inc. United States
TenCate Performance Composites United States
Machine Guard & Cover Co. United States
Arzeda Corporation United States

Recent Private Companies Transactions

April 28, 2015

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OPX Biotechnologies, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at